Evidence map›Paper›PMID 32102646›Full record

Trial reportCritical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine2020

Sodium bicarbonate in 5% dextrose: can clinicians tell the difference?

Briony Jude, Thummaporn Naorungroj, Ary Serpa Neto, Tomoko Fujii, Andrew Udy, Rinaldo Bellomo

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Sodium bicarbonate therapy for metabolic acidosis in critically ill patients: a survey of Australian and New Zealand intensive care clinicians.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2020
    Trial
  2. Protocol summary and statistical analysis plan for the sodium bicarbonate for metabolic acidosis in the intensive care unit (SODa-BIC) trial.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Briony JudeDepartment of Intensive Care and Hyperbaric Medicine, Alfred Hospital, Melbourne, VIC, Australia.
Thummaporn NaorungrojDepartment of Intensive Care Medicine, Austin Hospital, Melbourne, VIC, Australia.
Ary Serpa NetoDepartment of Intensive Care Medicine, Austin Hospital, Melbourne, VIC, Australia.
Tomoko FujiiAustralian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Andrew UdyDepartment of Intensive Care and Hyperbaric Medicine, Alfred Hospital, Melbourne, VIC, Australia. andrew.udy@monash.edu.
Rinaldo BellomoDepartment of Intensive Care Medicine, Austin Hospital, Melbourne, VIC, Australia.
Austin Hospital · AUMonash University · AUThe Alfred Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDue to the lack of double-blind randomised controlled trials, the true effect of intravenous sodium bicarbonate therapy in ICU patients with metabolic acidosis remains unclear.

methodsWe diluted 100 mL 8.4% sodium bicarbonate in 150 mL 5% dextrose (D5W) within a 250 mL polyolefin bag after removing 100 mL. We asked ICU clinicians to inspect a 250 mL bag containing sodium bicarbonate or a 250 mL bag where 100 mL of D5W had been removed and then returned. The bags were attached to intravenous giving sets. We asked participants to identify the contents of the bags.

resultsAmong 60 participants (39 nursing staff [65%], 20 medical staff [33.3%] and one pharmacist), 36 (60%) answered correctly. The Cohen κ for agreement between test bag content and participants' answers was 0.20 (95% CI, -0.05 to 0.45;

conclusionWhen 100 mL of 8.4% sodium bicarbonate were diluted in 150 mL of D5W within a 250 mL polyolefin bag, clinicians were unable to correctly identify the contents of the bags. Our findings imply that sodium bicarbonate therapy can be successfully blinded.

Indexed as

AcidosisAdministration, IntravenousDouble-Blind MethodElectrolytesGlucoseHumansInjections, IntravenousSodiumSodium BicarbonateTreatment OutcomeElectrolytesGlucoseSodiumSodium Bicarbonate

Identifiers

PMID32102646
PMCPMC10692479
OpenAlexW3011818937

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.